All posts in Breaking News

It was announced today that Baxter has done something Stryker seemingly has been unable (or unwilling) to. They have entered into a definitive agreement to acquire Apatech. Many

We have been very happy to provide news and discussion topics to you in our current/updated form for over two months now. We have seen our readership grow

By: Ben Craigs This past week, OrthoSpineNews attended Robin Young’s 5^th annual Stem Cell Summit in New York City.  We see this emerging market as the next frontier for

The past 2 years in Orthopedics and Spine have been turbulent to say the least. The big companies had to deal with investigations of kickbacks, deferred prosecution agreements,

There has been much ado about Kyphoplasty and Vertebroplasty in recent months beginning with the study published by the New England Journal of Medicine. Normally a well respected

We have been hearing rumblings over the past few months about a war going on between Osteotech and Apatech. In head to head competition, Osteotech totals revenues of

In the same week that Blue Cross / Blue Shield has issued a press release that they are extending Blue Distinction to over 800 facilities, it has been

Bernstein analyst Derrick Sung sees the U.S. hip and knee market growing 6 percent in the fourth quarter and recovering to 8 percent in 2010 due to easier

It was announced today that Robbins Umeda LLP will formally investigate Stryker Corporation for possible mismanagement. “Robbins Umeda LLP's investigation of Stryker concerns questionable statements issued by the

Love him or hate him the Spineblogger is here to stay. Over the last year a new website popped up called The Spineblogger (www.spineblogger.blogspot.com). This anonymous person

Dec. 31 (Bloomberg) -- The Mayo Clinic, praised by President Barack Obama as a national model for

“I hear that Brad from the Billion Dollar Computer Company is looking for a job…must be good if he reached management there. And he can probably get up to

It is simply impossible to extend health-care benefits to an additional 32 million people without significantly increasing cost. As we know, as government costs go up, taxes go

WASHINGTON, Nov 2 (Reuters) - U.S. reviewers have raised the possibility of bias in the evaluation of a spine device made by Zimmer Holdings Inc (